CYP2C9 and CYP2B6 Polymorphisms

0.0(0)
Studied by 3 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/16

encourage image

There's no tags or description

Looks like no tags are added yet.

17 Terms

1
New cards

polymorphisms of pharmacodynamic target of Warfarin

  • VKORC1

  • CYP4F2

  • GCCX


2
New cards

pharmacoDYNAMIC targeting: VKORC1

  • low levels will cause low levels of reduced vitamin K → lower warfarin dose

  • c. -1693G>A (rs9923231)


3
New cards

pharmacoDYNAMIC targeting: CYP4F2

  • reduced function will cause high levels of reduced vitamin K → increase warfarin dose

  • CYP4F2*3/*3


4
New cards

PharmacoKINETIC targeting of Warfarin: CYP2C9

  • CYP2C9*2/*2, CYP2C9*3/*3

  • increases levels of warfarin → lower warfarin dose

    • usually east asians and oceanic


5
New cards

therapeutic plan for warfarin based on pgx test results for VKORC1 and CYP2C9

knowt flashcard image
6
New cards

T or F: PGx replaces INR monitoring

false

7
New cards

most impactful variable on warfarin dose is —

known non-genetic factors

  • age

  • sex

  • race

  • weight

  • height


8
New cards

clinical trials on warfarin: COAG

  • genotype vs clinically guided

  • ethically diverse

  • CYP2C9, VKORC1


9
New cards

clinical trials on warfarin: EU-PACT

  • genotype vs fixed dose

  • homogenous european population

  • CYP2C9, VKORC1


10
New cards

clinical trials on warfarin: GIFT

  • RCT on safety

  • genotype vs clinically guided

  • CYP2C9, VKORC1, CYP4F2*3

  • “Genotype-guided dosing may improve the safety of warfarin initiation among patients undergoing hip or knee arthroplasty”


11
New cards

— is the most commonly used algorithm

warfarindosing.com

12
New cards

CYP2B6*6 & *9

  • decreased function

  • most common in AA and oceanian


13
New cards

CYP2B6*18

no function

14
New cards

CYP2B6*4

increased function

15
New cards

Efavirenz

600 mg PO daily (“one pill, once a day” regimen)


16
New cards

decreased activity of CYP2B6 will — active efavirenz concentration

  • increase concentration → higher risk of CNS toxicity


17
New cards

therapeutic plan for efavirenz based on PGx test results for CYP2B6

knowt flashcard image